Gut, Digestive, and Metabolic Conditions
Women's Health
Oral Health
Skin Health and Personal Care
Infant Health
Nutrition
Microbial Therapeutics, FMT and Probiotics
Infectious Diseases and Antimicrobial Resistance
Neurology and Mental Health
Immuno-oncology
Clinical Trials and Regulatory Expertise
Personal Testing
Agriculture
Aquaculture
Companion Animals
AMR and Disease Surveillance
Wastewater
Soil Health and Bioremediation
Production Safety and Contaminant Tracking
Microbial Strain Characterization
Shotgun Metagenomics
Long-Read Metagenomics
Marker Gene Analysis
Microbiome Profiling
Absolute Abundance
Overview
Untargeted Metabolomics Panels
Targeted Metabolomics Panels
Metatranscriptomics / Transcriptomics
Proteomics
Sampling Kit and Project Handling 
Biostatistics
Machine Learning and AI 
Integrative Systems Biology and Multi-Omics
Strain Tracking and Engraftment
News
Case Studies
Webinars
Leadership Team
Laboratory
Certifications
CareersShotgun Metagenomics and Functional Profiling
Our best-in-class metagenomics pipelines offer taxonomic and functional profiling, revealing how microbial communities and their metabolic pathways affect cancer progression and treatment responses.
Clonal-Level Profiling
Understanding strain-level differences is essential for oncology, particularly when tracking engraftment of live biotherapeutic products (LBPs) or fecal microbiota transplants (FMT). Our snv-based clonal-level profiling provides data on strain differences, engraftment, persistence, and their impact on treatment outcomes.
Responder/Non-Responder Analysis
We analyze microbiome and metabolomics differences between responders and non-responders to cancer therapies, helping you identify biomarkers that may predict treatment success and guide personalized therapeutic approaches.
Metabolite Analysis for Cancer Treatment
Microbial metabolites such as short-chain fatty acids (SCFAs) and immune-regulating compounds can impact cancer progression and treatment responses. Our targeted and untargeted metabolomics panels provide detailed data on these metabolites, allowing you to explore the links between microbial activity and cancer therapy.
Proteomics
Our targeted oncology panel helps you explore the expression of microbial proteins that may influence tumor development or interact with cancer treatments, providing a deeper understanding of microbial-host interactions in the cancer context.
Human Genomics
We offer human genome sequencing and analysis to explore the interactions between host genetics and the microbiome in cancer. This service allows you to investigate how genetic variations in patients influence microbiome composition, immune responses, and treatment outcomes, providing a more comprehensive view of cancer biology and personalized treatment strategies.
